GlassScriptPhysician profile
Michael Lee Rolfsen
NPI 1760724553
$1,916.80
in general payments reported to CMS, 2019-2025
14 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.91 · 2020: $118 · 2021: $269 · 2022: $381 · 2023: $472 · 2024: $227 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000 · Honoraria: $32.44 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.37 |
| Honoraria | $32.44 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $715.94 | 2019-2025 | Clareon, Argos, Unity |
| Rxsight INC | $367.95 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Sight Sciences, INC. | $194.48 | 2021-2025 | Omni Surgical System |
| Abbvie INC. | $185.46 | 2019-2024 | Alphagan P, Lumigan |
| Allergan, INC. | $153.11 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $86.32 | 2022-2024 | Envista Mx60 Iol, Miebo |
| Biotissue Holdings INC. | $49.49 | 2020 | |
| Glaukos Corporation | $38.78 | 2021 | |
| Ocular Therapeutix, INC. | $33.91 | 2021-2022 | |
| Oyster Point Pharma, INC. | $29.50 | 2023 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $20.44 | 2022 | |
| Kala Pharmaceuticals, INC. | $16.14 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.14 | 2019 | |
| Shire North American Group INC | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rolfsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.